Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its Persona Revision SoluTion Femur.
Medical Device Network on MSN4d
FDA grants 510(k) clearance to Zimmer’s new revision knee implant componentThe US Food and Drug Administration (FDA) has granted 510(k) clearance to Zimmer Biomet's new revision knee implant component ...
Zacks Investment Research on MSN19h
Zimmer Biomet Focuses on Innovation Amid Growing CompetitionZimmer Biomet Holdings, Inc. ZBH is participating in the ongoing American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting in San Diego, from March 10-14. Here, the company is highlighting ...
Zimmer Biomet’s flagship robot, Rosa, is expected to make gains in the near future, CEO Ivan Tornos said at the Barclays 27th Annual Global Healthcare Conference. Mr. Tornos said adoption of the robot ...
Proficio Capital Partners LLC bought a new position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) during ...
In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report).
GlobalData on MSN16d
Zimmer Biomet and Arnold Schwarzenegger promote joint health via new campaignZimmer Biomet, one of the largest orthopaedic medtech companies ... Joint replacement, a surgical procedure where an implant is used to fix an impacted joint, is usually recommended when ...
The Terminator actor teamed up with Zimmer Biomet to raise awareness about osteoarthritis, which affects more than 25 million ...
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona® Revision SoluTion™ Femur, a ...
Cusack Park is to be renamed following a new commercial partnership between Clare GAA and American firm Zimmer Biomet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback